–
Статьи в журналах
-
- 2020 Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- Finn Richard S., Ryoo Baek-Yeol, Merle Philippe, Kudo Masatoshi, Bouattour Mohamed, Lim Ho Yeong, Breder Valeriy, Edeline Julien, Chao Yee, Ogasawara Sadahisa, Yau Thomas, Garrido Marcelo, Chan Stephen L., Knox Jennifer, Daniele Bruno, Ebbinghaus Scot W., Chen Erluo, Siegel Abby B., Zhu Andrew X., Cheng Ann-Lii
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 38, № 3, с. 193-202 DOI